You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:
en/oxfam-report-says-top-drug-companies-focusing-on-patents-not-the-poor#c45626

Oxfam report "Investing for Life": Company responses

Author: Compiled by the Business & Human Rights Resource Centre, Published on: 12 December 2007

The Business & Human Rights Resource Centre invited all 12 [pharmaceutical] companies to respond to the report. The results to date are below (any future responses received will be added to this page)...On 6 February 2008 Oxfam sent a rejoinder, commenting on the company responses...
- Abbott Laboratories, AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi-Aventis responded
- Roche, Eli Lilly declined to respond
- Bristol-Myers Squibb, Wyeth did not respond

Read the full post here

Related companies: Abbott Laboratories AstraZeneca Bristol-Myers Squibb Eli Lilly GlaxoSmithKline Johnson & Johnson Merck Novartis Pfizer Roche Sanofi Wyeth (part of Pfizer)